Teladoc Health, Inc.
TDOC
$7.59
$0.141.88%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.20% | -1.64% | -2.59% | -3.03% | -2.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.20% | -1.64% | -2.59% | -3.03% | -2.99% |
| Cost of Revenue | 4.14% | 1.32% | 1.18% | -2.32% | -3.34% |
| Gross Profit | -4.67% | -2.87% | -4.22% | -3.33% | -2.85% |
| SG&A Expenses | -6.01% | -1.41% | -5.65% | 5.78% | -4.24% |
| Depreciation & Amortization | -1.34% | -3.69% | -10.24% | -8.20% | -5.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.79% | -1.98% | -5.38% | -1.13% | -5.27% |
| Operating Income | 12.16% | 6.42% | 28.72% | -40.90% | 30.99% |
| Income Before Tax | -54.55% | 95.15% | -40.49% | -89.84% | 45.44% |
| Income Tax Expenses | -191.67% | -299.87% | -778.62% | -93.23% | 131.40% |
| Earnings from Continuing Operations | -48.78% | 96.10% | -13.58% | -67.56% | 41.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.78% | 96.10% | -13.58% | -67.56% | 41.70% |
| EBIT | 12.16% | 6.42% | 28.72% | -40.90% | 30.99% |
| EBITDA | -20.25% | -83.90% | 10.91% | -73.01% | 1.70% |
| EPS Basic | -44.23% | 96.23% | -9.40% | -61.03% | 43.87% |
| Normalized Basic EPS | -14.85% | 25.85% | 36.52% | -133.95% | 48.61% |
| EPS Diluted | -44.23% | 96.23% | -9.40% | -61.03% | 43.87% |
| Normalized Diluted EPS | -14.85% | 25.85% | 36.52% | -133.95% | 48.61% |
| Average Basic Shares Outstanding | 3.17% | 3.34% | 3.83% | 4.04% | 3.86% |
| Average Diluted Shares Outstanding | 3.17% | 3.34% | 3.83% | 4.04% | 3.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |